Using bone cement to improve surgery outcomes for hip fractures

Influence of Cemented Cephalic Augmentation on the Outcome of Osteosynthesis Using Intramedullary Nailing in the Surgical Treatment of Pertrochanteric Hip Fractures in the Elderly

NA · Fundacin Biomedica Galicia Sur · NCT06634290

This study is testing if using bone cement during hip fracture surgery can help older patients recover better and avoid complications.

Quick facts

PhaseNA
Study typeInterventional
Enrollment314 (estimated)
Ages75 Years and up
SexAll
SponsorFundacin Biomedica Galicia Sur (other)
Locations6 sites (Monforte de Lemos, Lugo and 5 other locations)
Trial IDNCT06634290 on ClinicalTrials.gov

What this trial studies

This clinical trial investigates whether adding bone cement to the intramedullary nailing technique improves surgical outcomes for patients with pertrochanteric hip fractures. Participants aged 75 and older will be randomly assigned to receive either the standard surgical procedure or the modified procedure with bone cement. The study aims to determine if this modification reduces complications related to mechanical failure of the implant and the need for re-operation. The trial will be conducted across multiple hospitals, ensuring a diverse patient population.

Who should consider this trial

Good fit: Ideal candidates are patients aged 75 and older diagnosed with a pertrochanteric fragility fracture requiring surgical intervention.

Not a fit: Patients with hip fractures of subtypes other than those specified or with significant comorbidities that contraindicate surgery may not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could lead to fewer complications and re-operations for elderly patients with hip fractures.

How similar studies have performed: While similar approaches have been explored, this specific use of bone cement in intramedullary nailing for this type of fracture is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 75 years of age or older.
* Diagnosis with a pertrochanteric fragility fracture.
* Informed consent for participation in the study.

Exclusion Criteria:

* Not meeting the inclusion criteria described above.
* Refusal of the patient or his/her legal representative to participate in the study.
* Diagnosis with hip fracture of subtypes other than 31A1, 31A2, 31A3 and 31B3 of AO-OTA classification.
* Bilateral hip fractures in the same episode.
* Suffering from previous medical pathologies or comorbidities that contraindicate surgical intervention and indicate conservative management of the fracture.
* Performing a surgical technique different from intramedullary nailing or using a surgical implant different from that used in the present study.

Where this trial is running

Monforte de Lemos, Lugo and 5 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Hip Fracture of Intertrochanteric Type, hip fracture, osteosynthesis, intramedullary nailing, bone cement augmentation

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.